Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Brytly (brytly (apraclonidine))FDA approves Brytly (brytly (apraclonidine))16 October 2026The FDA approved Brytly (brytly (apraclonidine)), a drug from Alcon Laboratories, Inc.. Form: Solution/ Drops. Application NDA220341.FDA New Drug Approvals calendarMore from this calendar

20 October 2026 - FDA approves Hibsago (bepirovirsen)

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)